Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices 32933 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name 

Number of 

respondents/ 

POCs 

Number of 

responses 

per POC 

Hours per 

response 

Total burden 

hours 

Total .......................................................................................................... NA NA NA 54 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name 

Number of 

respondents/ 

POCs 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Eligibility/Registration Forms ............................................................................ 40 2 $46.45 $93 

Data Use Agreement ....................................................................................... 40 2 46.45 93 

Nursing Home Site Information Form .............................................................. 40 10 46.45 465 

Data Files Submission ..................................................................................... 40 40 46.45 1,858 

Total .......................................................................................................... NA 54 NA 2,509 

* The wage rate in Exhibit 2 is based on May 2019 National Industry-Specific Occupational Employment and Wage Estimates, Bureau of Labor 

Statistics, U.S. Dept. of Labor. Mean hourly wages for nursing home POCs are located at https://www.bls.gov/oes/current/naics3_623000.htm. 

The hourly wage of $46.45 is the weighted mean of $47.32 (General and Operations Managers 11–1021; N=26) and $44.82 (Medical and Health 

Services Managers 11–9111; N=14). 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: June 16, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–13126 Filed 6–22–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0034] 

Advisory Committee on Immunization 

Practices (ACIP); Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Advisory Committee 

on Immunization Practices (ACIP); June 

23, 2021 and June 24, 2021, 9:00 a.m.– 

5:30 p.m., EDT (times subject to 

change), in the original FRN. 

The virtual meeting was published in 

the Federal Register on Monday, April 

5, 2021, Volume 86, Number 63, page 

17606. 

The virtual meeting is being amended 

to add an additional date, June 25, 2021 

and time, update meeting times and 

supplemental information and should 

read as follows: 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP please visit the 

ACIP website: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on June 

23, 2021, from 10:00 a.m. to 5:00 p.m., 

EDT (times subject to change); June 24, 

2021, from 10:30 a.m. to 5:10 p.m., EDT 

(times subject to change); and June 25, 

2021, from 10:00 a.m. to 12:20 p.m., 

EDT (times subject to change). Written 

comments must be received on or before 

June 25, 2021. 

A notice of this ACIP meeting has also 

been posted on CDC’s ACIP website at: 

http://www.cdc.gov/vaccines/acip/ 

index.html. In addition, CDC has sent 

notice of this ACIP meeting by email to 

those who subscribe to receive email 

updates about ACIP. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, GA 30329– 

4027; Telephone: 404–639–8367; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions on cholera 


jbell on DSKJLSW7X2PROD with NOTICES
32934 Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices 

vaccine, dengue vaccine, ebola vaccine, 

hepatitis vaccines, herpes zoster 

vaccines, influenza vaccines, 

orthopoxvirus vaccine, pneumococcal 

vaccine, rabies vaccine and tickborne 

encephalitis vaccine. Recommendation 

votes on dengue vaccine, ebola vaccine, 

influenza vaccines and rabies vaccine 

are scheduled. Vaccines for Children 

(VFC) votes on dengue vaccine and 

influenza vaccines are scheduled. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda visit https://

www.cdc.gov/vaccines/acip/meetings/ 

meetings-info.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web; for more information on ACIP 

please visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children Program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the June 23–25, 

2021, ACIP meeting must submit a 

request at http://www.cdc.gov/vaccines/ 

acip/meetings/ no later than 11:59 p.m., 

EDT, June 18, 2021, according to the 

instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by June 21, 2021. To accommodate the 

significant interest in participation in 

the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may only speak once per meeting. 

Written Public Comment: The docket 

will be opened to receive written 

comments on June 1, 2021. Written 

comments must be received on or before 

June 25, 2021. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–13120 Filed 6–22–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE21–006: 

Rigorously Evaluating Programs and 

Policies To Prevent Child Sexual 

Abuse (CSA); Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—CE21– 

006: Rigorously Evaluating Programs 

and Policies to Prevent Child Sexual 

Abuse (CSA); July 13–14, 2021, 8:30 

a.m.–5:00 p.m., EDT. 

The videoconference meeting was 

published in the Federal Register on 

March 29, 2021, Volume 86, Number 58, 

page 16369. 

The meeting is being amended to 

update the contact person and should 

read as follows: 

FOR FURTHER INFORMATION CONTACT: 

Aisha Wilkes, M.P.H., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop S106–9, 

Atlanta, Georgia 30341, Telephone: 

(404) 639–6473; Email: awilkes@

cdc.gov. 

The meeting is closed to the public. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–13121 Filed 6–22–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control, (BSC, NCIPC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC). This meeting 

is partially open to the public. There 

will be 15 minutes allotted for public 

comments at the end of the open session 

from 11:40 a.m., to 11:55 p.m., EDT. 

DATES: The meeting will be held on July 

29, 2021, from 10:00 a.m. to 12:00 p.m., 

EDT (OPEN); and from 12:30 p.m., to 

4:15 p.m., EDT (CLOSED). 

ADDRESSES: Open Session: Webinar, 

Atlanta, Georgia. All participants must 

register using the link provided to 

attend the open meeting: https://

dceproductions.zoom.us/webinar/ 

register/wn_cz3nu0zfsg29fiojefau8q. 

Closed Session: Teleconference. 

FOR FURTHER INFORMATION CONTACT: 

Gwendolyn H. Cattledge, Ph.D., 

M.S.E.H., Deputy Associate Director for 

Science, NCIPC, CDC, 4770 Buford 

Highway NE, Mailstop S106–9, Atlanta, 


jbell on DSKJLSW7X2PROD with NOTICES